PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 52: Articles 25501-26000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Family planning policy and community-based innovations in Thailand.
  2. Family planning program: a study on the recorded clients of rural Bangladesh.
  3. Family planning programs and fertility decline.
  4. Family planning realities in the third world.
  5. Family planning services by traditional birth attendants.
  6. Family planning services: a guide for client education.
  7. A family planning survey.
  8. Family planning targets by states for India (under alternative programme strategies to reach demographic goal of NRR=1 during the decade 1991-2001.
  9. Family planning training and supervision: review of the development of a guide for the primary health care project in Peru.
  10. Family planning users: comparing local survey and clinic records in the Philippines.
  11. Family planning without doctors.
  12. Family planning, socio-political ideology, and black Americans: a comparative study of leaders and a general population sample.
  13. Family planning. [Planificacion familiar.]
  14. Family planning: as important for the child as for the mother and for the family [interview with Prime Minister Indira Ghandi]
  15. Family planning: "Billings" ovulation method (author's transl) [Planejamento familiar metodo deaovulacao "Billings".]
  16. Family planning: a guide to methods for fieldworkers, health, social and welfare workers.
  17. Family planning: implications for marital stability.
  18. Family planning: improving the health of women and their children.
  19. Family planning: issue paper.
  20. Family planning: the pill or natural method of birth control (author's transl) [Familienplanung - pille oder naturliche methoden.]
  21. Family planning: the task of the medical schools. [Planificacao familiar: o papel das escolas de medicina.]
  22. Family size and fertility related knowledge and attitudes of Turkish youth in villages with differential exposure to family planning programs.
  23. Family size attitudes and use of contraception in Sydney: Australian, Greek and Italian parents.
  24. Family--planning or fate: socio-demographic and intra-family aspects of the attitude of married German women to family planning and abortion--results of a longitudinal analysis. [Famile--Planung oder Schicksal: sozio-demographische und innerfamiliare Aspekte der Einstellung deutscher Ehefrauen zu Familienplanung und Schwangerschaftsabbruch--Ergebnisse einer Longitudinalanalyse.]
  25. Family-planning program effects and attitudes of adolescent females toward authority.
  26. Family-planning services: categorical versus comprehensive.
  27. Fatal myocardial infarction and the role of oral contraceptives.
  28. Female breast cancer: distribution, risk factors, and effect of steroid contraception.
  29. Female education, fertility and family planning behavior in Peninsular Malaysia.
  30. Female surgical contraception: state-of-the-art.
  31. Fertility and family planning in Fiji.
  32. Fertility and family planning in Greater Bombay.
  33. Fertility and family planning in Indonesia: summary of M.A. thesis.
  34. Fertility and family planning in Mexico.
  35. Fertility and family planning in Yugoslavia.
  36. Fertility and family planning: a case study of Ngao District, Lampang, Thailand.
  37. Fertility and subfertility as health problems: population control versus family planning by the family.
  38. Fertility awareness: individual-controlled contraception.
  39. Fertility control in women 35 years and older: the role of intrauterine steroidal contraception. [Abstract]
  40. Fertility decline and family planning in Reunion. [Baisse de fecondite et planification familiale a la Reunion.]
  41. Fertility preferences and contraceptive use: a regional analysis.
  42. Fertility regulation and family planning.
  43. Fertility, development and family planning: cross-sectional and dynamic analyses.
  44. Fetal damage caused by contraceptive tablets. [A fogamzasgatlo tablettak magzati artalmassaga.]
  45. Fewer adverse effects of oral contraceptives. [Faerre biverkningar av p-piller.]
  46. Fibrocystic breast disease: contraindication for oral contraceptive therapy.
  47. The fight for family planning: the development of family planning services in Britain 1921-74.
  48. Final report on the impact of the Integrated Family Planning and Parasite Control Programme in Thailand January 1977 - February 1980.
  49. First FDA medical device regulations will affect development of many experimental contraceptives.
  50. Fitting and extrapolating contraceptive continuation curves by logit regression.
  51. Five-year plan for family planning services and population research, submitted by the Secretary of Health and Human Services.
  52. Flower intrauterine contraceptive device.
  53. Focal hemorrahagic necrosis of the liver: a clinicopathological entity possibly related to oral contraceptives.
  54. Focal nodular hyperplasia of the liver and hepatic cell adenoma in women on oral contraceptives.
  55. Folate for oral contraceptive users may reduce cervical cancer risk.
  56. Folk methods of birth control.
  57. A follow-up survey of family planning methods in general practice in Victoria.
  58. Foreword: IUDs and family planning programs.
  59. Four case histories with severe genital infections following insertion of intrauterine contraceptive devices (author's transl) [Bericht uber 4 falle einer ernsten genitalen infektion nacheinlage von intrauterinepessaren.]
  60. Freedom of choice of contraceptive methods.
  61. From confrontation to cooperation: the evolution of a family planning programme for Kampuchean refugees.
  62. From non-use to use: prospects of contraceptive adoption in Pakistan.
  63. From the integrated family planning-nutrition-parasite control program to primary health care.
  64. Future developments in intrauterine contraception.
  65. The future of contraception. [O futuro da contracepcao.]
  66. Genetic counselling for neurological and psychic diseases. Pt. 1. Data on counsellees and their pre- and post-counselling family planning.
  67. Genital infections in prenatal and family planning attendants in Swaziland.
  68. Giant cell thromboangiitis in a patient taking an oral contraceptive (author's transl) [Thromboangeite a cellules geantes au cours s'une contraception orale: etude anatomo-clinique et immunologique.]
  69. Glucose and insulin levels in relation to the use of combination-type oral contraceptive drugs.
  70. Government of Tunisia/USAID mid-project evaluation of the Tunisian family planning program: Report of the mission concerning Phase II. [Gouvernement de la Tunisie/USAID evaluation de mi-projet du Programme de Planification Familiale Tunisient: compte-rendu de la mission interessant la Phase II.]
  71. A guide to contraceptive advice.
  72. A guide to the methods of contraception.
  73. Guizhou County censured for poor planned parenthood work.
  74. Guizhou officials punished for birth control failures.
  75. Guizhou planned parenthood circular.
  76. Haemostatic changes associated with hormonal contraception: a multicentric study of an Italian population.
  77. Hageman factor deficiency and oral contraceptives. [Letter]
  78. Handout on population and family planning.
  79. Has legal abortion replaced other methods of birth control? (author's transl) [Har legal abort ersatt annan fodelsekontroll?]
  80. Health and family planning services for a growing population: a prediction model of family planning acceptance and it implication for health services in rural India.
  81. Health implications of family planning in Egypt.
  82. Health instructions concerning sexual activities and birth control.
  83. Health personnel requirements for providing contraceptive services and availability of such personnel in Nepal.
  84. Health personnel requirements for providing contraceptive services and availability of such personnel in Sri Lanka.
  85. Health personnel requirements for providing contraceptive services and the availability of such personnel.
  86. Health services and the family planning component.
  87. The health team approach to planned parenthood II: report.
  88. Health-integrated approach to family planning in Viet Nam.
  89. The hemostatic mechanism and menstruation: the role of intra-uterine contraceptive devices.
  90. Hemostatic mechanism in the normal endometrium and endometrium exposed to contraceptive steroids.
  91. Henan planned parenthood meeting.
  92. High estrogen content oral contraceptives continued availability.
  93. His Royal Majesty's Government of Nepal Family Planning and Maternal and Child Health Project; vol. I. Financial Management.
  94. Histological and cytological changes in women using intrauterine contraceptive devices (authors' transl) [Histologische und zytologische veranderungen bei IUD-tragerinmen.]
  95. Histological and histo-chemical changes in ovary under the effect of oral contraceptives.
  96. Historical styles of contraceptive advocacy.
  97. Hormonal contraception and hearing disorders (author's transl) [Hormonalni antikoncepce a poruchy sluchu.]
  98. Hormonal contraception--whence, how, and whither?
  99. Hormonal contraception: side effects and surgical aspects (author's transl) [Hormonale Kontrazeption--Anwendung und Nebenwirkungen.]
  100. Hormonal contraceptive therapy and thromboembolic disease. [Terapeutica anticonceptive hormonal y enfermedad tromboembolica.]
  101. Hormonal contraceptives.
  102. Hormonal methods for male contraception.
  103. Household contraceptive distribution evaluation study.
  104. How family planning associations can supplement and compliment the government's population family planning programmes.
  105. Human reproduction: bioengineering aspects of contraception applied to the development of a new female contraceptive.
  106. Human rights from humanitarian perspectives: an international comparative appraisal of state laws on and practice of abortion and sterilization as means of family planning.
  107. Humanae Vitae and natural family planning.
  108. Hyperplastic lesions and benign tumors associated with oral contraception: report of 10 cases (author's transl) [Lesions hyperplasiques et tumorales benignes associees a une contraception orale: a propos de 10 cas.]
  109. Hypertension and contraceptive therapy (author's transl) [Hypertension arterielle et contraceptifs oraux.]
  110. Hypertension and hormonal contraceptives. [Hypertonie und hormonale Kontrazeptiva.]
  111. Hypertension in 45 females on oral contraceptives. [Hypertension arterielle chez 45 femmes sous contraceptif oestro-progestatif.]
  112. Identification of quality of life indicators for use in family planning programs in developing countries.
  113. Identifying adolescents at risk for noncompliance with contraceptive therapy.
  114. Immediate postplacental insertion of intrauterine contraceptive devices (author's transl) [Insertion des D.I.U. dans le post-partum immediat.]
  115. Immune reactivity of women on hormonal contraceptions: phytohemagglutinin and concanavalin A-induced lymphocyte response.
  116. Immunology of contraception.
  117. Impact of an outreach family planning service program in Philippine rural villages.
  118. The impact of restrictions on the provision of birth control and abortion services on teenage fertility. [Tables]
  119. Impact of the national family planning program on fertility levels in Korea: multivariate areal analysis.
  120. Impaired elimination of caffeine by oral contraceptive steroids.
  121. Implementation of family planning services as part of primary health care.
  122. The importance of the prolactin level in the development and treatment of amenorrhea-galactorrhea caused by hormonal contraceptives. [A prolactin-szint jelentosege a hormonalis fogamzasgatlas okozta amenorrhoea-galactorrhoea kifejlodeseben es kezeleseben.]
  123. Incidence of endometrial cancer in relation to the use of oral contraceptives.
  124. Incidence of hyperprolactinemia during oral contraceptive therapy.
  125. Increased blood viscosity in young women using oral contraceptives.
  126. Increasing frequency of extrauterine pregnancy: correlation with contraceptive practice? [Oekende hyppighet av extrauterin graviditet: sammenheng med prevensjonspraksis?]
  127. An incremental-dose combined oestrogen-progestogen oral contraceptive: cycle control and endometrial changes.
  128. An incremental-dose combined oestrogen-progestogen oral contraceptive: effects on body weight, blood pressure, and biochemical parameters.
  129. Indications for oral contraceptives: recommendations of the Swiss Family Planning Association. [Indikation fur Ovulationshemmer: Empfehlungen der Schweizerischen Gesellschaft fur Familienplanung.]
  130. Indications for ovulation inhibitors. Recommendations of the Swiss Society for Family Planning. [Indikation fuer Ovulationshemmer. Empfehlungen der Schweizeriscchen Gesellschaft fuer Familionplanung.]
  131. Indonesia: family planning program: orientation booklet.
  132. Indonesia: family planning target stepped up for 1980; twofold success of integrated project.
  133. Indonesia: progress report of the integrated family planning and parasite control project.
  134. The Indonesian population and family planning program through charts and pictures (publisher's translation) [Program Nasional kependudukan dan keluarga berencana dalam grafik dan gramar.]
  135. Infant mortality and family planning.
  136. Influence of age, cigarette smoking and oral contraceptive on plasma concentrations of clomipramine.
  137. The influence of contraceptive steroids on the histochemistry and cytochemistry of the normal endometrium.
  138. The influence of contraceptive steroids on the histological appearance of the endometrium.
  139. Influence of contraceptive steroids on tumor development in experimental animals and man: a short review.
  140. Influence of environmental chemicals on drug therapy in humans: studies with contraceptive steroids.
  141. Influence of HLA types on carbohydrate effects of a low-estrogen oral contraceptive.
  142. The influence of traditional values and beliefs on family planning decisions in Thailand.
  143. The influence on oral contraceptive formulation on carbohydrate and lipid metabolism.
  144. The influences of Buddhism and Islam on family planning in Thailand: communication implication.
  145. Information, education and communication (IEC) strategies in Taiwan's family planning program.
  146. Injectable contraception.
  147. Injectable contraceptive Noristerat.
  148. Injectable contraceptive synthesis: an example of international cooperation.
  149. Injectable hormonal contraceptive in Mohammadpur Fertility Services and Training Centre.
  150. Injectable particulate contraceptive systems.
  151. Innovative approaches in contraceptive research.
  152. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
  153. Integrated family planning programs: conceptual and empirical considerations.
  154. Integrating family planning and home economics. Teachers guide/handbook.
  155. Integration of family planning and health services: the Narangwal experience.
  156. The integration of family planning within primary health care.
  157. Inter-spousal communication and practice of contraception in India.
  158. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy.
  159. Interim insertion of the ML Cu 250 intrauterine contraceptive device.
  160. An International Experience on the Clinical Use of Depo-Provera: final report to the International Planned Parenthood Federation.
  161. The international status of voluntary surgical contraception and its implications for national health programs.
  162. Interorganizational relations in the provision of family planning services.
  163. Intra-vaginal contraceptive methods. [Les methodes contraceptives intra-vaginales.]
  164. Intrahepatic cholestasis due to the association of triacetyloleandomycin and oestroprogestinic contraceptive combination. [Cholestase intrahepatique provoquee par l'association triacetyloleandomycine-oestroprogestatif.]
  165. Intrauterine contraception in nulliparous women (author's transl) [La contraccezione intrauterina nella nullipara.]
  166. Intrauterine contraception with the Copper 7 200 compared with the Multiload Cu 250.
  167. Intrauterine contraception with the Progestasert system.
  168. Intrauterine contraceptive (abortifacient) device. [Letter]
  169. Intrauterine contraceptive device use and pelvic inflammatory disease.
  170. Intrauterine contraceptive device use in patients with acute salpingitis.
  171. Intrauterine contraceptive devices: evaluation by sonography.
  172. Intravaginal contraceptive sponge impregnated with nonoxynol-9. The development of sponge for clinical efficacy trials.
  173. The introduction of the Norplant to family planning programs: an overview.
  174. Introduction to family planning.
  175. Introduction to the anthropological guide to be used in the development of family planning programs in indigenous communities of Guatemala.
  176. Inventory of selected local family planning programme experiences in countries of the ESCAP region. Vol. 1.
  177. Inventory of selected local family planning programme experiences in countries of the ESCAP region. Vol. 2.
  178. An investigation of the association between cervical cancer and oral contraceptive usage.
  179. Involving young men in family planning: an evaluation of a sex education project for men.
  180. IPPF-ESRAOR panel on the effects of steroidal contraceptives on Asians.
  181. IPREFA: Education, health, family planning--an integrated project in Honduras.
  182. Iran: [family planning program]. [Letter]
  183. Irreversible contraception in women: a supplementary method of family planning. [Die irreversible Kontrazeption bei der Frau: eine erganzende Methode der Familienplanung: literaturubersicht und eigen erfahrunge.]
  184. Is what we are offering acceptable? The case of family planning acceptance in Indonesia.
  185. Islam and family planning: Indonesia's Mohammadiyah.
  186. Islam conference endorses family planning.
  187. Islamic Africa endorses family planning.
  188. Issues in male involvement in family planning: cross-cultural observations based on Japanese data.
  189. Issues in the measurement of potential fertility of contraceptive acceptors.
  190. IUD and family planning in Brazil. [Abstract]

     

  191. IUD and family planning in Islamic populations.
  192. IUD and family planning in Islamic populations. [Abstract]
  193. The IUD as a contraceptive possibility. [El dispositivo intrauterino como posibilidad contraceptiva.]
  194. IUDs and family planning in Brazil.
  195. IUDs and family planning in Indonesia.
  196. IUDs and family planning in Latin America and Spain.
  197. IUDs and family planning in Nigeria.
  198. IUDs and family planning in South Africa.
  199. IUDs and family planning in South-East Asia.
  200. IUDs and family planning in Sri Lanka and Pakistan.
  201. IUDs and family planning in Thailand.
  202. IUDs and family planning in the Middle East.
  203. IUDs and family planning in the Netherlands.
  204. IUDs and family planning in the United States.
  205. IUDs and family planning in the USSR.
  206. Japan's abortion laws and birth control ambitions in the underdeveloped countries in Asia.
  207. Jaundice and hepatic hemangioma after ten years of oral contraception and recent administration of triacetyloleandomycin. [Ictere et Hemangiome hepatique apres dix ans de contraception orale et administration recente de triacetyloleandomycine.]
  208. Jaundice from troleandomycin and oral contraceptives. [Letter]
  209. Jaundice in early pregnancy with concomitant intake of oral contraception (author's transl) [Tidlig forekomst af icterus under graviditet og p-pilleindtagelse.]
  210. Jaundice in women taking both troelandomycin and oral contraceptives, an outbreak in France (author's transl) [Une Epidemie d'icteres due a l'association troleandomycine-contraceptifs oraux.]
  211. Joint IGCC/IPPF-ESEAOR Workshop on Optimal Use of Resources for National Population/Family Planning Programs.
  212. Joint social marketing promotion of a weaning food and a contraceptive in Sri Lanka.
  213. Jordan: fertility averages 7.3 births per woman; only 26 percent use efficient contraceptive method.
  214. Kenya's maternal, child health/family planning program.
  215. Knowledge and use of contraceptives: a comparative analysis with data from reports from Latin American countries. [Concimiento y uso de metodos anticonceptivos: un analisis comparativo con datos de los informes de paises en America Latina.]
  216. Knowledge of contraceptive methods.
  217. Knowledge, attitude and practice of family planning in a rural Nigerian Community: Igbogbo.
  218. Knowledge, knowledge, who's got the knowledge? The male contraceptive career.
  219. Korea: progress report of the integrated family planning and parasite control project.
  220. Law and family planning: where do adolescents belong?
  221. Law and planned parenthood.
  222. Left ventricular size and function in women receiving oral contraceptives.
  223. Legal and policy aspects of contraceptive information and services.
  224. Legal regulations as an instrument of family planning. [Nasi pogledi na legislativno regulisanje kao instrumenta plantranja porodice.]
  225. Levels of contraceptive use and projected fertility decline in Pakistan: some alternative estimates.
  226. Liaoning family planning.
  227. Life table analysis of contraceptive use-effectiveness.
  228. Limited usefulness of the breath test in evaluation of drug metabolism: a study in human oral contraceptive users treated with dimethylaminoantipyrine and diazepam.
  229. Linking voluntary sterilization, family planning services, and health services.
  230. Lipoproteins in arteriopathy and in women on oral contraceptives.
  231. A literature review of the client-provider interface in maternal and child health and family planning clinics in Latin America.
  232. Liver and the contraceptive pill.
  233. Liver cancer and oral contraceptives. [Letter]
  234. Liver cell carcinoma in young women possibly induced by oral contraceptives.
  235. Liver function tests and low-dose estrogen oral contraceptives.
  236. Local contraception: positive and negative motivation (author's transl) [Contraception locale: motivations et resistences psychologiques.]
  237. Location of IUD use for contraception. [Abstract]
  238. A logistic regression analysis of attrition among Philippine contraceptive adopters.
  239. A logit regression method for the multivariate analysis of contraceptive attrition.
  240. Long-acting steroidal contraceptive systems.
  241. Long-term contraception with depo-provera: a clinical evaluation.
  242. Long-term experience in intrauterine contraception: a comparison between Lippes' loop, Dalkon-Shield and Copper-T (author's transl) [Langzeiterfahrungen mit der intrauterinen Empfaengnis verhuetung: Ein Vergleich von Lippes-Schleife, Dalkonschild und Kupfer-F.]
  243. Long-term impact of family planning programs on women in three Asian countries [abstract]
  244. Luteinizing hormone releasing hormone and analogues, conceptive and contraceptive potential.
  245. Luteolytic activity of LHRH and [D-SER(TBU)<6> >DES-GLY-NH2<10>] LHRH ethylamide: a new and physiological approach to contraception in women.
  246. Lysosome function in normal endometrium and endometrium exposed to contraceptive steroids.
  247. Malaysia: progress report on integrated family planning and parasite control project.
  248. Malaysian experience in managing policy and public support for family planning.
  249. Male contraception today.
  250. Male contraception without a prescription. [Contracepcao masculina sem prescricao.]
  251. Male contraception: will we get it? Do we want it?
  252. Management of the family planning programme: its performance in the seventies.
  253. Managing contraception in amenorrheic runners.
  254. Managing oral contraception.
  255. Managing teenage pregnancy: access to abortion, contraception, and sex education.
  256. Mass media and family planning Ibadan, Nigeria.
  257. Massive arterial thrombosis and oral contraception. [Letter]
  258. Massive arterial thrombosis and oral contraception. [Letter]
  259. Maternal and Child/Health Family Planning Program: Technical Workshop Proceedings, New York City, Oct 31-Nov 2, 1979.
  260. A mathematical model of family planning for population control.
  261. The Matlab family planning health services project.
  262. Measurement by isotope dilution mass spectrometry of 17alpha-ethynyloestradiol-17beta and norethisterone in serum of women taking oral contraceptives.
  263. Measuring the input of family planning programs.
  264. The mechanism of action of a new low-dosed combined oral contraceptive.
  265. Medicaid in FY 78: states fund abortions, U.S. covers other family planning services.
  266. Medical risks associated with natural family planning.
  267. Medical supervision for contraception.
  268. Medical topics: contraceptive pills and hepatobiliary cancer.
  269. Medico-legal implications of family planning.
  270. Medroxyprogesterone acetate (Depo-Provera): an injectable contraceptive.
  271. Men and family planning.
  272. Men's sexual and contraceptive work biographies and the management of contraception.
  273. Mennonite Central Committee Family Planning Program--Bangladesh.
  274. Menstrual cycle and oral contraceptive effects on alcohol pharmacokinetics in Caucasian females.
  275. Menstrual regulation clients in a village-based family planning programme.
  276. Metabolic effects of oral contraceptives: clinical considerations.
  277. Methods for determining contraceptive effectiveness.
  278. Methods for evaluating contraceptive techniques.
  279. Methods of contraception, with special reference to sterilization (letter) [A fogamzasgatlas modszereirol, Kulonos tekintettel a sterilizalasra.]
  280. Methods of family planning. Book 3: the oral pill.
  281. Mexico: progress report of the integrated family planning and parasite control project.
  282. Migraine attacks and multiple strokes related to prolonged oral contraceptive treatment in a case of multi-infarct dementia.
  283. Migraines and headaches during oral contraception. [Migraines et cephalees au cours de la contraception orale.]
  284. Minigest--a new Czechoslovak contraceptive and its side effects (author's transl) [Minigest--novy ceskoslovensky antikoncepcni preparat a jeho vedlejsi uciny.]
  285. Minimum medical service standards for male voluntary surgical contraception programs.
  286. Mode of action of triphasic oral contraception.
  287. Modern contraceptive methods.
  288. Modern methods of contraception.
  289. Modernity characteristics of local leaders and the family planning program in Bangladesh.
  290. Modification in the contraceptive behavior in Sorocaba in a period of 11 years (1968-1979) (author's transl) [Modificacoes nos habitos anticonceptionais em Sorocaba em um periodo de 11 anos (1968-1979)]
  291. Modifications of coagulation factors in women taking oral contraceptives. [Modifications des facteurs de la coagulation au cours de la contraception orale.]
  292. The modified mucus method of family planning.
  293. More than 100 million contraceptive operations have been done in 9 years.
  294. Morphological changes in the endometrium of women using an intrauterine contraceptive device. [Morfologicheskie izmeneniia v endometrii zhenshchin pri primenenii vnutrimatochnogo protivozachatochnogo svedstva.]
  295. Morphological feature of the epididymis: possible significance in male contraception.
  296. Mozambique to introduce family planning services.
  297. National Contraceptive Prevalence Survey with Fertility/Mortality Module. Estimations of fertility and mortality at the national level, September-December, 1979, Mexico. [Encuesta Nacional de Prevalencia en el Uso de Metodos Anticonceptivos con Modulo Fecundidad/Mortalidad. Estimaciones de fecundidad y mortalidad a nivel nacional, Septiembre a Diciembre de 1979, Mexico.]
  298. National Contraceptive Prevalence Survey with Fertility/Mortality Module. Methodological document presented in discussion at the Colegio de Mexico, April 17-18, 1980. [Encuesta Nacional de Prevalencia en el Uso de Metodos Anticonceptivos con Modulo Fecundidad/Mortalidad. Documento metodologico presentado a discusion en el Colegio de Mexico el 17 y 18 de abril de 1980.]
  299. National fertility survey, family planning and communication survey, Guatemala (ENPAG/78). Pt. 1. Fertility and family planning. [Encuesta nacional de fecundidad planificacion familiar y communicacion de Guatemala (ENPAG.78). Primera parte. Fecundidad y planificacion familiar.]
  300. National fertility, family planning and mass communication survey, El Salvador (FESAL-78). Pt. l. Fertility and family planning. [Encuesta nacional de fecundidad planificacion familiar y communicacion masiva de El salvador (FESAL-78). Primera Parte. Fecundidad y planificacion familiar.]
  301. National Fertility, Family Planning, and Mass Communication Survey, El Salvador, 1978 (FESAL-78): general findings. [Encuesta Nacional de Fecundidad, Planificacion Familiar y Comunicacion Masiva, El Salvador, 1978. (FESAL-78) resultados generales.]
  302. The national policy for population and family planning.
  303. The National Reporting System for Family Planning Services--a new look.
  304. Natural birth control.
  305. Natural family planning (NFP) developmental tasks: programme implementation, quality control and instructor training implementation.
  306. Natural family planning in pictures (companion volume to "Natural Approach to Family Planning")
  307. Natural family planning in the United States of America: status and prospects.
  308. Natural family planning program. [Programme der Naturlichen Familienplanung (NFP)]
  309. Natural family planning programs development and evaluation.
  310. Natural family planning.
  311. Natural family planning. 2. Basal body temperature and estimated time of ovulation.
  312. Natural family planning: a detailed survey of previous studies, combined with the author's personal research.
  313. Natural family planning: tension in the ranks.
  314. Natural family planning: will it have a rebirth? Government supports natural planning alternative.
  315. Natural family planning: will it have a rebirth? Systemized gambling? Proponents say No.
  316. Natural methods of family planning.
  317. The need for research in family planning.
  318. The Nepal Family planning program: a report on an administrative management consultancy.
  319. Nepal project paper: integrated rural health/family planning services.
  320. Nepal: progress report of the integrated family planning and parasite control project.
  321. Networks and resource sharing in family planning libraries and documentation centres.
  322. Neurofibromatosis and oral contraceptive therapy [Answer to letter of Lawrence M. Nelson]
  323. Neurologic and psychiatric symptoms associated with taking oral contraceptives. [Neurologische und psychiatrische Symptome bei der Einnahme von Ovulationshemmern.]
  324. Neurological and cerebrovascular pathology during treatment with oral contraceptives. [Patologia vascolare encefalica e neurologica in corso di trattamento con contraccettivi orali.]
  325. New context for contraception teaching.
  326. New directions for contraception.
  327. New directions in community based family planning in Brazil.
  328. New discoveries in the field of population mathematics, applicable to planning and evaluation of population and family planning program in Indonesia.

     

  329. New perspectives for contraception.
  330. No association between oral contraceptives and malignant melanomas [letter]
  331. No-pill no-risk birth control.
  332. Nonprescription vaginal contraception.
  333. The nonspermicide fit-free diaphragm: a new contraceptive method.
  334. Nonsurgical methods of contraception.
  335. The normal menstrual cycle and oral contraceptives: the physiological basis for a triphasic approach.
  336. Nosology of contraceptives: hematological and ultrastructural observations after experimental administration of low dosage contraceptives (author's transl) [Nosografismo iatrogeno da contraccettivi: rilievi ematochimici ed ultrastrutturali dopo somministrazione sperimentale di estroprogestinici a basso dosaggio.]
  337. A note concerning abortion and contraception among the Nzema of Ghana. [Note sull'aborto e la contraccezione tra gli Nzema del Ghana.]
  338. The nurse and contraception for adolescents. [L'infirmiere et la contraception a l'adolescence.]
  339. The nurse practitioner's role in family planning.
  340. Nurse's role in voluntary pregnancy interruption and contraception. [Role de l'infirmiere face a l'intervention volontaire de grossesse et a la contraception.]
  341. The Nutrition Education Center in Serpong, Tangerang, West Java: The Nutrition Component of the Indonesian Integrated Parasite Control Family Planning and Nutrition Project.
  342. Nutrition education in a family planning clinic.
  343. Nutritional effects of oral contraceptive use: review.
  344. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose.
  345. Obtaining contraceptives.
  346. Ocular side effects through oral contraceptives (authors' transl) [Nebenwirkungen oraler kontrazeptiva am auge.]
  347. Of feminism and birth control propaganda (1790-1840)
  348. On selecting an estimate of current contraceptive use in India: a preliminary review of data sources.
  349. On the subject of contraception (author's transl) [A propos de la contraception.]
  350. Operational guidelines and procedures for natural family planning programs.
  351. Opinion survey shows educated Indians favor mandatory birth control.
  352. Oral and injectable contraceptives: effects on breast milk and child growth in Bangladesh.
  353. Oral and injectable contraceptives: the effects on breastmilk and child growth in Bangladesh.
  354. Oral contraception and congenital abnormalities.
  355. Oral contraception and oral mucosa. [Contraception orale et muqueuse buccale.]
  356. Oral contraception and the skin. [La pilule et la peau.]
  357. Oral contraception and thromboembolism: the role of progestogens.
  358. Oral contraception and thromboembolism: the role of progestogens. [Editorial]
  359. Oral contraception and thromboembolism: the role of progestogens. [Letter]
  360. Oral contraception using an ultra-low-dose Progestogen-only Pill containing 0.34 mg Norgestrianone (author's transl) [Contraception orale microprogestative continue par Norgestrienone a 0.350 mg.]
  361. Oral contraception. [La contraception orale.]
  362. Oral contraceptive hazards.
  363. Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients.
  364. Oral contraceptive steroids and atherosclerosis: lipogenesis in human arterial smooth muscle cells and dermal fibroblasts in presence of lipoprotein-deficient serum from oral contraceptive users.
  365. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.
  366. Oral contraceptive use and diseases of the circulatory system in Taiwan: an analysis of mortality statistics.
  367. Oral contraceptive use in relation to non-fatal myocardial infarction.
  368. Oral contraceptive-induced chorea.
  369. Oral contraceptive-induced hepatic adenoma and focal nodular hyperplasia.
  370. Oral contraceptives abstracts: a guide to the literature, 1977-1979.
  371. Oral contraceptives and benign tumorous conditions of the liver (author's transl) [Orale Kontrazeptiva und gutartige tumorose Veranderungen der Leber.]
  372. Oral contraceptives and birth defects.
  373. Oral contraceptives and breast cancer.
  374. Oral contraceptives and cardiovascular disease.
  375. Oral contraceptives and coronary thrombosis: two clinico-pathological cases. [Pilule contraceptive et thrombose coronaire: deux cas anatomo-cliniques.]
  376. Oral contraceptives and endometrial cancer. [Editorial]
  377. Oral contraceptives and exercise.
  378. Oral contraceptives and family health in rural Bangladesh.
  379. Oral contraceptives and liver neoplasia. [Ovulationshemmer und Leberneoplasien.]
  380. Oral contraceptives and nutrient requirements.
  381. Oral contraceptives and pap smear changes: clinical comments.
  382. Oral contraceptives and physiological variables.
  383. Oral contraceptives and pituitary adenomas.
  384. Oral contraceptives and post-molar trophoblastic tumours. [Letter]
  385. Oral contraceptives and prolactin-producing hypophyseal tumors. [Orale anticonceptiva en prolactine producerende hypofysetumoren.]
  386. Oral contraceptives and pyridoxine deficiency: biochemical and clinical facts.
  387. Oral contraceptives and responsiveness of plasma renin activity and blood pressure in normotensive women.
  388. Oral contraceptives and sex hormone binding globulin capacity.
  389. Oral contraceptives and systemic lupus erythematosus.
  390. Oral contraceptives and the prothrombin time. [Letter]
  391. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.
  392. Oral contraceptives in risk patients. [Kontrazeption bei Risikopatientinnen.]
  393. Oral contraceptives norethindrone and mestranol: effect on serum vitamin A, retinol-binding protein and prealbumin in women [abstract]
  394. Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion.
  395. Oral contraceptives said to protect against PID.
  396. Oral contraceptives, risk factor of myocardial infarction related to blood lipids (author's transl) [Pilule-Lipides sanguins et risque coronarien.]
  397. Oral contraceptives, side effects and drug interactions.
  398. Oral contraceptives: experience of the last 10 years. [Contraceptifs oraux: experience des 10 dernieres annees.]
  399. Oral contraceptives: liver diseases in 25 million women. [Contraceptifs oraux: des troubles hepatiques chez 25 millions de femmes.]
  400. Oral contraceptives: mechanisms in thromboembolism.
  401. Oral contraceptives: misunderstood etiology of erythema nodosum (author's transl) [Contraceptifs oraux: etiologie meconnue des erythemes noueux.]
  402. Oral-contraceptive-associated liver tumours. [Letter]
  403. oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis.
  404. The organisational structure of the International Planned Parenthood Federation (IPPF)
  405. Organization determinants of performance of family planning services in selected ESCAP countries: the Singapore Study.
  406. Organizational determinants of family planning programme performance: evaluation of integrated family planning programmes in the ESCAP region. Report of a Study Directors' Meeting.
  407. Organizational determinants of family planning programs performance: evaluation of integrated family planning programs in the ESCAP region: report of a Study Directors' Meeting.
  408. Organizational determinants of performance in family planning services in selected ESCAP countries: the Malaysian study.
  409. Organizational determinants of performance in family planning services in selected ESCAP countries: the Philippines National Study.
  410. Organizational determinants of performance in family planning services in selected ESCAP countries: the Republic of Korea Study.
  411. The origins of the birth control movement in England in the early nineteenth century.
  412. Our experience with IUD for birth control. [Nustra experiencia conlos dispositivos intrauterinos (DIU) para el control de la natalidad.]
  413. Outcome of pregnancies following the use of oral contraceptives.
  414. An overview of family planning in Korea.
  415. An overview of luteal phase contraception.
  416. Pakistan's family planning program.
  417. Para-medical personnel and family planning in Sri Lanka.
  418. Para-medical personnel in population control and family planning.
  419. Paramedical personnel use in family planning in South East Asia.
  420. Paramedical personnel use in family planning in South East Asia. [Abstract]
  421. Parents need not be told child gets contraceptives.
  422. Participation exercises applied to family planning courses. [Ejercicios de participacion aplicados a cursos de planificacion familiar.]
  423. Participation of government and non-government organizations in United Nations decisions on birth control; a problem in organization theory.
  424. A pastor's experience with natural family planning.
  425. Pathology subordinate to the use of oral contraceptives (author's transl) [Patologia secondaria all'uso di contraccettivi orali.]
  426. The pattern of supply, distribution and use of oral contraceptive pill in rural areas in Uttar Pradesh.
  427. Patterns of bleeding associated with the use of steroidal contraceptives.
  428. Peer pressures and the use of contraceptive sterilization in rural Bangladesh.
  429. Pelvic actinomycosis following insertion of an intrauterine contraceptive device.
  430. People's perception about family planning in India: a study of Andhra Pradesh and Bihar.
  431. Peptides: a new hormonal approach to contraception.
  432. Perceived side effects of oral contraceptives among adolescent girls.
  433. Perihepatitis in pelvic inflammatory disease: association with intrauterine contraception.
  434. Permanent birth control, choice of 12 million Americans.
  435. Personal experience with contraception in Algeria (author's transl) [Notre experience de la contraception en Algerie.]
  436. Personalized contraceptive use-effectiveness estimation: a potential tool for counselling.
  437. Perspectives of physiologic contraception. [Perspectives pour une contraception physiologique.]
  438. The pharmacist and family planning: new roles and responsibilities.
  439. The pharmacist and family planning: status and prospects.
  440. Pharmacological aspects of oral contraceptives (author's transl) [Aspects pharmacologiques des contraceptifs oraux: les antigestagenes.]
  441. Pharmacological aspects of oral contraceptives: part 2 (author's transl) [Aspects pharmacologiques des contraceptifs oraux: les antigestagenes; 2 partie.]
  442. Pharmacology of male contraception.
  443. Pharmacology of male contraception. [Farmacologia de contracepcao masculina.]
  444. Philippines: progress report of the Family Planning/Parasite Control/Nutrition Integration Pilot Project.
  445. Philosophical background for humanistic family planning.
  446. The physiological basis for natural family planning.
  447. Phytoestrol in the hormone free interval of hormonal contraceptive use. [Phytoestrol im hormonfreien Intervall bei Ovulationshemmer-Einnahme.]
  448. Pitfalls in the legalization of abortion for failed contraception [letter]
  449. Pitfalls in the legalization of abortion for failed contraception. [Letter]
  450. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive.
  451. The place of intrauterine device (IUD) insertion in a maternal-child-health family planning (MCH/FP) integrated approach in rural areas. [Letter]
  452. Planned parenthood and women's development: an analysis of experience.
  453. Planned parenthood for women's development--a non issue in Singapore?
  454. Planned Parenthood-World Population Special Report: Family Planning Services and Population Research: Appropriations for Title X of the Public Health Service Act.
  455. Planning of pregnancy and birth control in Valladolid. [Planificacion del embarazo y anticoncepcion en Valladolid.]
  456. Planning your family the S-T way. 2nd. ed.
  457. Plasma alpha-feto protein levels and its relation to duration of oral contraception use.
  458. Plasma progesterone levels in normal and pregnant Chinese women and effects of contraceptives on them.
  459. Plasma tocopherol and lipid levels in pregnancy and oral contraceptive users.
  460. The politics of contraception: the view from Beijing.
  461. The politics of family planning policy: Thailand--a case of successful implementation.
  462. Population and family planning programs: a compendium of data through 1978. 10th ed.
  463. Population control and family planning programme in Bangladesh.
  464. Population control family planning in Bangladesh.
  465. Population growth, economic growth, and family planning programs in less developed countries.
  466. Population impact of development intervention: an analysis of family planning performance variance in the districts of Bangladesh.
  467. Population policy and family planning communication strategies in the Arab states region. Vol. 1. Summaries of pertinent literature and research studies.
  468. Population policy and family planning programs: trends in policy and administration.
  469. The population problem and family planning in Egypt.
  470. Population, health and family planning in Tunisia. [Population, sante et planification familiale en Tunisie.]
  471. Population/family planning problems and programs in the International Year of the Child.
  472. A possible communications strategy for the Family Planning Association of Kenya (FPAK)
  473. Possible role of lactation in family planning.
  474. Post-coital contraception.
  475. Post-partum contraception.
  476. Postcoital contraception with an injectable estrogen preparation (ORG 369-2)
  477. Postcoital contraception.
  478. Postpartum IUDs: a boon to family planning.
  479. Praxis and commitment in family planning education: evaluation of an in-service program with home economists in Panama.
  480. Prediction and detection of ovulation as related to fertility and contraception.
  481. Predictors relating to implementation of family planning policy in the Philippines.
  482. Preferences for sweet in relationship to use of oral contraceptives and pregnancy.
  483. Pregnancy attributable to interaction between tetracycline and oral contraceptives.
  484. Pregnancy under oral contraceptives after treatment with tetracycline. [Grossesse sous contraceptifs oral apres prise de tetracycline.]
  485. A preliminary assessment of the feasibility of a subsidized contraceptive marketing program in the Dominican Republic.
  486. A preliminary assessment of the feasibility of a subsidized contraceptive marketing program in Trinidad-Tobago.
  487. Preliminary experience with a sub-50 combined oral contraceptive, containing 35 micrograms ethinyl oestradiol and 1 mg norethisterone (Neo Con)
  488. Preliminary experience with Noristerone Enanthate: an injectable contraceptive.
  489. Preliminary report on the use of Noristerat as contraceptive in 100 consecutive self motivated users in a private clinic.
  490. Preliminary testing of the contraceptive collagen sponge.
  491. Premarital contraceptive behavior: attitudes among adolescents.
  492. Premarital relations and birth control. Recent trends. [Relations pre-nuptiales et prevention de la grossesse. Evolution recente.]
  493. Prenatal diagnosis and genetic counseling in 21 trisomy: its impact on family planning.
  494. Prescribing an oral contraceptive for the individual woman.
  495. Prescription of oral contraceptives by family planning nurses.
  496. Present management of abnormal bleeding associated with steroidal contraceptives.
  497. Prevalence and demographic significance of contraceptive sterilization in Fiji, the Republic of Korea, and Sri Lanka.
  498. Prevalence of anemia in women attending family planning clinic in Durango (author's transl) [La prevalencia de anemia en mujeres asistentes a servicios de planificacion familiar en la ciudadde Durango.]
  499. Prevalence of contraceptive use in Colombia: determinants and implications. [Prevalencia del uso de anticoncepcion en Colombia: determinantes e implicaciones.]
  500. Prevalence of contraceptive use in Colombia: determinant factors and policy implications.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.